| # | Title | Journal | Year | Citations |
|---|
| 1 | Mycophenolate mofetil and its mechanisms of action | Immunopharmacology | 2000 | 1,208 |
| 2 | Mechanisms of action of cyclosporine | Immunopharmacology | 2000 | 687 |
| 3 | Inhibition of p38 MAP kinase as a therapeutic strategy | Immunopharmacology | 2000 | 449 |
| 4 | C1q: Structure, function, and receptors | Immunopharmacology | 2000 | 449 |
| 5 | Kinin B1 receptors: a review | Immunopharmacology | 1995 | 378 |
| 6 | LKPNM: a prodrug-type ACE-inhibitory peptide derived from fish protein | Immunopharmacology | 1999 | 332 |
| 7 | Complement components of the innate immune system in health and disease in the CNS | Immunopharmacology | 2000 | 324 |
| 8 | Immunosuppressive drugs: the first 50 years and a glance forward | Immunopharmacology | 2000 | 320 |
| 9 | Tricyclic antidepressants inhibit IL-6, IL-1β and TNF-α release in human blood monocytes and IL-2 and interferon-γ in T cells | Immunopharmacology | 1996 | 302 |
| 10 | Thalidomide selectively modulates the density of cell surface molecules involved in the adhesion cascade | Immunopharmacology | 1996 | 284 |
| 11 | Regulation of complement activation by C-reactive protein | Immunopharmacology | 1999 | 272 |
| 12 | Biological effects of the human complement fragments C5a and C5ades Arg on neutrophil function | Immunopharmacology | 1980 | 269 |
| 13 | Mechanisms of action of methotrexate | Immunopharmacology | 2000 | 263 |
| 14 | Microglial and astrocytic involvement in a murine model of Parkinson's disease induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) | Immunopharmacology | 1998 | 261 |
| 15 | Vascular leak syndrome: a side effect of immunotherapy | Immunopharmacology | 1997 | 252 |
| 16 | Leflunomide: an immunomodulatory drug for the treatment of rheumatoid arthritis and other autoimmune diseases | Immunopharmacology | 2000 | 246 |
| 17 | Therapeutic intervention with complement and β-glucan in cancer | Immunopharmacology | 1999 | 238 |
| 18 | Immunomodulation by bromocriptine | Immunopharmacology | 1983 | 236 |
| 19 | Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors | Immunopharmacology | 2000 | 233 |
| 20 | In vitro effects of echinacea and ginseng on natural killer and antibody-dependent cell cytotoxicity in healthy subjects and chronic fatigue syndrome or acquired immunodeficiency syndrome patients | Immunopharmacology | 1997 | 232 |
| 21 | The inhibitory effect of polysaccharides isolated from Phellinus linteus on tumor growth and metastasis | Immunopharmacology | 1999 | 226 |
| 22 | Sensory neuropeptides: their role in inflammation and wound healing | Immunopharmacology | 1997 | 220 |
| 23 | The use of mycophenolate mofetil in transplant recipients | Immunopharmacology | 2000 | 215 |
| 24 | The flavonoid baicalin exhibits anti-inflammatory activity by binding to chemokines | Immunopharmacology | 2000 | 208 |
| 25 | Stress proteins and the immune response | Immunopharmacology | 2000 | 206 |
| 26 | Activation of a mouse macrophage cell line by acemannan: The major carbohydrate fraction from Aloe vera gel | Immunopharmacology | 1996 | 197 |
| 27 | The structure of inosine 5′-monophosphate dehydrogenase and the design of novel inhibitors | Immunopharmacology | 2000 | 192 |
| 28 | The factor H protein family | Immunopharmacology | 1999 | 180 |
| 29 | Δ9 Tetrahydrocannabinol and cannabidiol alter cytokine production by human immune cells | Immunopharmacology | 1998 | 177 |
| 30 | Host recognition and target differentiation by factor H, a regulator of the alternative pathway of complement | Immunopharmacology | 2000 | 169 |
| 31 | Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA | Immunopharmacology | 1999 | 159 |
| 32 | CD14 and other recognition molecules for lipopolysaccharide: A review | Immunopharmacology | 1995 | 154 |
| 33 | Controlling the complement system in inflammation | Immunopharmacology | 1997 | 151 |
| 34 | Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics | Immunopharmacology | 2000 | 147 |
| 35 | Characteristic immunostimulation by angelan isolated from Angelica gigas Nakai | Immunopharmacology | 1998 | 146 |
| 36 | The immunomodulatory and antitumor activities of lectins from the mushroom Tricholoma mongolicum | Immunopharmacology | 1996 | 145 |
| 37 | Complement factors and their receptors | Immunopharmacology | 1997 | 145 |
| 38 | Vascular actions of synthetic PAF-acether (a synthetic platelet-activating factor) in the rat: Evidence for a platelet independent mechanism | Immunopharmacology | 1982 | 144 |
| 39 | Derivation of RNA aptamer inhibitors of human complement C5 | Immunopharmacology | 1999 | 138 |
| 40 | Angioedema due to angiotensin-converting enzyme inhibitors | Immunopharmacology | 1999 | 137 |
| 41 | PGG-Glucan, a soluble β-(1,3)-glucan, enhances the oxidative burst response, microbicidal activity, and activates an NF-κB-like factor in human PMN: Evidence for a glycosphingolipid β-(1,3)-glucan receptor | Immunopharmacology | 1999 | 135 |
| 42 | Cellular and genetic basis for suppression of cytotoxic T cell generation by haloaromatic hydrocarbons | Immunopharmacology | 1983 | 132 |
| 43 | The isolation and characterization of an immunomodulatory and anti-tumor polysaccharide preparation from Flammulina velutipes | Immunopharmacology | 1997 | 131 |
| 44 | Triptolide induces apoptotic death of T lymphocyte | Immunopharmacology | 1998 | 131 |
| 45 | Peptidergic pathway in human skin and rat peritoneal mast cell activation | Immunopharmacology | 1994 | 129 |
| 46 | Differential regulation by thalidomide and dexamethasone of cytokine expression in human peripheral blood mononuclear cells | Immunopharmacology | 1998 | 129 |
| 47 | Complement systems in invertebrates. The ancient alternative and lectin pathways | Immunopharmacology | 1999 | 127 |
| 48 | Suppression of experimetal autoimmune encephalomyelitis by cannabinoids | Immunopharmacology | 1994 | 125 |
| 49 | Inhibition of interleukin-12 and interferon-γ production in immune cells by tanshinones from Salvia miltiorrhiza | Immunopharmacology | 2000 | 125 |
| 50 | Stimulation of in vivo antibody production and concanavalin-A-induced mouse spleen cell mitogenesis by prolactin | Immunopharmacology | 1987 | 117 |
